Vesamicol is an experimental drug, acting presynaptically by inhibiting acetylcholine uptake into synaptic vesicles and reducing its release. Vesamicol may have applications for the treatment of adenocarcinoma in situ of the lung. References: Ogawa K, Masuda R, Mizuno Y, Makino A, Kozaka T, Kitamura Y, Kiyono Y, Shiba K, Odani A. Development of a novel radiobromine-labeled sigma-1 receptor imaging probe. Nucl Med Biol. 2018 Apr 6;628-35. doi: 10.1016/j.nucmedbio.2018.03.005. [Epub ahead of print] PubMed PMID: 29704822.

纯度：≥98%

CAS：22232-64-0